Heparin Market
Europe held largest market share in heparin market during the forecast period due to increasing demand for heparin for cardiovascular diseases, sports injuries
PORTLAND, OREGON, US, October 9, 2022 /EINPresswire.com/ -- Growing demand for atrial fibrillation treatment and heparin-induced thrombocytopenia in the treatment of thrombotic stroke is driving the growth of the global anticoagulant market. The increasing prevalence of arterial hypertension, diabetes, and obesity are key factors propelling the growth of the anticoagulant market. The high cost and limited availability for these treatments have acted as major constraints for adoption of heparin in commercial. According to Allied Market Research, the Heparin Market is projected to reach $11,015 million by 2028, registering a CAGR of 6.6% from 2021 to 2028.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ@ https://www.alliedmarketresearch.com/request-sample/6551
As heparin is extracted from animal sources, it poses major safety and supply concerns, which also hampers market growth. Conversely, the availability of synthetic and semi-synthetic heparin mimetics that aid in the treatment of various cancers, coagulation and inflammatory diseases is expected to provide lucrative opportunities for heparin product adoption. Increased government support to improve healthcare infrastructure and robust R&D initiatives to produce heparin with enhanced therapeutic potential and fewer side effects are expected to create lucrative opportunities for the industry.
๐๐๐ฒ ๐๐๐ ๐ฆ๐๐ง๐ญ๐ฌ
On the basis of application, the market is segmented into venous thromboembolism, atrial fibrillation, coronary artery disease, and others. Venous thromboembolism is expected to generate the highest revenue during the forecast period due to the increasing incidence of thromboembolic disorders due to hospital stays, alcoholism, smoking, cancer chemotherapy, and pregnancy.
By distribution channel, it is classified into hospital pharmacies, drug stores and retail pharmacies and online pharmacies. The hospital pharmacy segment accounted for the most revenue in 2020 and is expected to maintain its dominance over the forecast period.
Europe held the largest market share in the global heparin market in 2020 and is expected to remain dominant during the forecast period due to increasing demand for heparin for cardiovascular diseases and sports injuries.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ@ https://www.alliedmarketresearch.com/purchase-enquiry/6551
๐๐๐๐๐ข๐ง๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
Baxter International Inc.,
B. Braun Holding GmbH & Co. KG,
Dr. Reddy's Laboratories Ltd.,
Fresenius SE & Co KGAA,
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.,
Leo Pharma A. /S,
Pfizer Inc.,
Sanofi S.A,
Teva Pharmaceuticals,
Viatris Inc.
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Surgical Robotic System Market
Plant Tissue Culture Market
๐๐๐จ๐ฎ๐ญ ๐๐ฌ: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
